Before Nick Hanauer was a Seattle billionaire and political activist, he was an early investor in Amazon. Now, he says the city’s next big thing is curing cancer.
Hanauer called out Juno Therapeutic’s (Nasdaq: JUNO) innovative immunotherapy cancer treatments during the GeekWire Summit in Seattle on Thursday. The treatments involve engineering patients’ cells to better battle disease and infusing those blood cells back into the body.